MRNS I like it for Monday ... will DD further M
Post# of 658
Marinus Pharmaceuticals, Inc. (MRNS) 2.22 +0.46 (+26.14%) pick up few more cents in a/h but only on 23k volume
Day's Range 1.75 - 2.38
Volume 6,399,238
Avg Vol (3m) 914,418
Quote:
MRNS has surged by nearly 23% today after the company provided an update on its Phase 2 trial evaluating the efficacy of open-label ganaxolone as an adjunctive therapy for uncontrolled seizures in female children with PCDH19 mutation and other rare genetic epilepsies. The study will now be expanded to 50 patients, from the previous figure of 20. Marinus Pharmaceuticals Inc (NASDAQ:MRNS) shares are still down by 72% this year after ganaxolone failed a late-stage study in mid-June assessing its efficacy in treating adults with drug-resistant focal onset seizures. The number of hedge funds in our system long Marinus Pharmaceuticals stood at three at the end of the second quarter, with them holding approximately $1.3 million worth of the company’s shares.
Don't be afraid to be outnumbered. Pigeons flock together. Eagle fly alone